Background. Cytotoxic T lymphocytes (CTL) have been shown to be useful
for adoptive immunotherapy in malignancy. Traditional sources for CTL
, such as tumor-infiltrating lymphocytes, have limitations. It would t
herefore be useful to develop a method of generating antitumor CTL fro
m a renewable source such as peripheral blood. Methods. DBA/2 mice wer
e injected intradermally in the abdominal wall with the murine tumor P
HS-5 and killed 14 days later. Peripheral blood lymphocytes were harve
sted and cultured with 20 units/ml interleukin-2 and autologous tumor-
stimulator cells treated with mitomycin C. Cultures were split when gr
eater than 2 X 10(6) cells/well, fed every 3 days and stimulated weekl
y. Results. Lymphocytes expanded greater than 130,000-fold during 8 we
eks. Specific cytotoxicity was shown with Cr-51 release assay. Withdra
wal of repeated stimulation with autologous tumor resulted in failure
of cells to expand in culture and loss of cytotoxicity. In vivo admini
stration showed marked reduction of 10-day liver metastases, indicatin
g therapeutic efficacy. Conclusions. These data demonstrate a successf
ul animal model of adoptive immunotherapy with CTL generated from peri
pheral blood lymphocytes.